pSivida Corp (PSDV) today published a new blog post on The Chairman’s Blog, written by the company’s President and CEO, Dr. Paul Ashton. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
After elaborating on the age-related macular degeneration (AMD) and chronic diabetic macular edema (DME) markets and competitors in the space, Dr. Paul Ashton provides an overview of recent news regarding pSivida’s ILUVIEN: “Regarding our own product in this space, the last month or so has seen a flurry of good news on ILUVIEN, our sustained release insert approved in Europe for chronic DME.” Dr. Ashton also explains the profit split with ILUVIEN’s licensee, Alimera Sciences. Read the full blog post from Dr. Paul Ashton on TheChairmansBlog.com (http://www.thechairmansblog.com/paul-ashton/2013-05/big-and-small-picture.html).
pSivida Corp., headquartered in Watertown, MA, develops tiny, sustained release, drugs delivery products designed to release drugs at a controlled and steady rate for months or years. pSivida is currently focused on treatment of chronic diseases of the back of the eye utilizing its core technology systems, Durasert™ and BioSilicon™. Two FDA-approved products, Vitrasert™ and Retisert™ are licensed to Bausch & Lomb. The company has licensed ILUVIEN® for DME to Alimera Sciences and that product has received marketing authorization in Austria, France, Germany, Portugal, Spain and the UK. pSivida has clinical trials ongoing for the treatment of posterior uveitis and glaucoma and ocular hypertension. Other technologies under development by pSivida include protein and antibody delivery systems in early clinical stages. www.pSivida.com
TheChairmansBlog.com is an exclusive, online media publication where publically and privatively held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. In addition to management`s insightful blog posts, TheChairmansBlog.com staff and aggregate partners contribute articles on finance, technology, health, and energy while providing updated market trends, news, and information. http://www.thechairmansblog.com/